Peer Reviewedhttps://deepblue.lib.umich.edu/bitstream/2027.42/154665/1/fsb2fj078653com.pd
SummaryLeukotriene B4 (LTB4) is a potent inflammatory mediator in asthma, and is increased in more s...
Background: Identifying therapeutic drugs that block the release or effects of T-helper type 2 (Th2)...
WOS: 000363025500001PubMed: 26385352Leukotrienes (LTs) are a family of inflammatory mediators includ...
Lipoxin A4 stable analogs reduce allergic airway responses via mechanisms distinct from CysLT1 recep...
Leukotrienes (LTs), including cysteinyl LTs (CysLTs) and LTB 4 , are potent lipid mediators that hav...
Chronic mucosal inflammation is the hallmark of important and common airway diseases, such as allerg...
AbstractLeukotrienes (LTs), both LTB4 and the cysteinyl LTs (CysLTs) LTC4, LTD4 and LTE4, are implic...
Leukotrienes (LTs), including cysteinyl LTs (CysLTs) and LTB4, are potent lipid mediators that have ...
BACKGROUND: In health, inflammation resolution is an active process governed by specialized proresol...
Cysteinyl leukotrienes (CysLTs) are a family of inflammatory lipid mediators synthesized from arachi...
Background: An imbalance in the generation of pro-inflammatory leukotrienes, and counter-regulatory ...
Biologics, including omalizumab, mepolizumab, benralizumab, and dupilumab, targeting downstream IgE,...
Airway diseases can disrupt tight junction proteins, compromising the epithelial barrier and making ...
Airway diseases can disrupt tight junction proteins, compromising the epithelial barrier and making ...
The resolution of inflammation is an integral and natural part of the physiological response to tiss...
SummaryLeukotriene B4 (LTB4) is a potent inflammatory mediator in asthma, and is increased in more s...
Background: Identifying therapeutic drugs that block the release or effects of T-helper type 2 (Th2)...
WOS: 000363025500001PubMed: 26385352Leukotrienes (LTs) are a family of inflammatory mediators includ...
Lipoxin A4 stable analogs reduce allergic airway responses via mechanisms distinct from CysLT1 recep...
Leukotrienes (LTs), including cysteinyl LTs (CysLTs) and LTB 4 , are potent lipid mediators that hav...
Chronic mucosal inflammation is the hallmark of important and common airway diseases, such as allerg...
AbstractLeukotrienes (LTs), both LTB4 and the cysteinyl LTs (CysLTs) LTC4, LTD4 and LTE4, are implic...
Leukotrienes (LTs), including cysteinyl LTs (CysLTs) and LTB4, are potent lipid mediators that have ...
BACKGROUND: In health, inflammation resolution is an active process governed by specialized proresol...
Cysteinyl leukotrienes (CysLTs) are a family of inflammatory lipid mediators synthesized from arachi...
Background: An imbalance in the generation of pro-inflammatory leukotrienes, and counter-regulatory ...
Biologics, including omalizumab, mepolizumab, benralizumab, and dupilumab, targeting downstream IgE,...
Airway diseases can disrupt tight junction proteins, compromising the epithelial barrier and making ...
Airway diseases can disrupt tight junction proteins, compromising the epithelial barrier and making ...
The resolution of inflammation is an integral and natural part of the physiological response to tiss...
SummaryLeukotriene B4 (LTB4) is a potent inflammatory mediator in asthma, and is increased in more s...
Background: Identifying therapeutic drugs that block the release or effects of T-helper type 2 (Th2)...
WOS: 000363025500001PubMed: 26385352Leukotrienes (LTs) are a family of inflammatory mediators includ...
DOI
Add to ORKG